Zeto gains FDA nod for new outpatient EEG system promising faster brain health testing

The FDA clearance of Zeto New Wave marks the company’s third cleared device, alongside Zeto WR19 and Zeto ONE

Exclusive | Bharat Biotech’s ROTAVAC halves severe diarrhoea hospitalisations in children, landmark Nature study confirms

Nature Medicine study delivers strongest real-world evidence yet for India’s indigenous rotavirus vaccine under UIP

Cadila Pharma launches triple-combination therapy for stronger BP control

The new single-pill therapy combines cilnidipine, telmisartan and metoprolol, bringing together three established antihypertensive agents with complementary mechanisms

NITI Aayog releases reports to improve ease of doing R&D in India

The reports will now be shared with relevant ministries and departments as a guidance framework

Chiba University study flags allergy risk in high-binding antibody drugs

For the biopharma industry, the study strengthens the case for balancing immune-cell engagement with tolerability in antibody discovery platforms

Metropolis’ ARSH initiative touches 3.25 Lakh adolescents, deepening grassroots health impact

CSR-led ‘Too Shy to Ask’ program expands across 1,000+ villages, with Panchayat-backed adolescent leadership driving behavioural change

Govt. of Madhya Pradesh, mlHealth360 launch AI radiology pilot in 10 district hospitals

At the center of deployment is mlHealth360’s proprietary Scaida AI platform, designed to detect and triage abnormalities in CT scans

India’s Dapagliflozin Moment: Why USFDA’s generic greenlight wave matters

In just the last few days, companies including Lupin, Biocon, Alembic Pharmaceuticals and Aurobindo Pharma have announced approvals for 5 mg and 10 mg tablets, all bioequivalent to Farxiga

Insmed’s Brensocatib fails to hit endpoints in hidradenitis suppurativa study

The results were consistent across both the 10 mg and 40 mg treatment arms

Stereotaxis bags FDA clearance for next-gen cath lab tech